Company Advanced Proteome Therapeutics Corp. Other OTC

Equities

CA0076281009

Investment Holding Companies

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Shell Companies

Inactive Instrument

Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.

Managers	Title	Age	Since
Paul Woodward CEO	Chief Executive Officer	63	18-04-15
Ken Phillippe DFI	Director of Finance/CFO	72	09-03-09
Martin Woodward BRD	Director/Board Member	56	18-12-19

Members of the board	Title	Age	Since
W. Catalano BRD	Director/Board Member	59	-
Martin Woodward BRD	Director/Board Member	56	18-12-19
Cory Brandolini BRD	Director/Board Member	64	22-11-20
Paul Woodward CEO	Chief Executive Officer	63	18-04-15

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	41,127,080	36,950,363 ( 89.84 %)	0	89.84 %

Name	Equities	%	Valuation
Conation Capital Corp. 6.438 %	2,647,837	6.438 %	15 887 $
Martin Woodward 1.330 %	546,950	1.330 %	3 282 $
Ken Phillippe 1.216 %	500,000	1.216 %	3 000 $
Paul Woodward 1.150 %	473,000	1.150 %	2 838 $
W. Catalano 0.7512 %	308,930	0.7512 %	1 854 $

Advanced Proteome Therapeutics Corp.

8337 Eastlake Drive Suite 104

V5A 4W2, Burnaby

+(604) 690-3797

address Advanced Proteome Therapeutics Corp.

Financials

Holding Companies

Holding Companies

Investment Holding Companies

Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+180.51%	8.67B
CHURCHILL CAPITAL CORP VII	+2.29%	983M
APPLE ISPORTS GROUP, INC.	+41.91%	883M
PERELLA WEINBERG PARTNERS	+26.17%	825M
ARES ACQUISITION CORPORATION II	+1.92%	665M
E7 GROUP	+9.52%	664M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+9.17%	530M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies